1 |
Heo JG. Jung-ui-bang-je-hak. Seoul: Eum- yang -maek-gin Publishing; 1991, p. 174-5.
|
2 |
Kim GJ, Kim JH, Chae BY. Anti-allergic and antiinflammatory analgesic effects of Hoechunyanggyeoksan. The J of Oriental Medical Surgery, Ophthalmology & Otolaryngology 1994;7(1):1-13.
|
3 |
Kang SW, No SS. Experimental study on the anti-inflammatory and wound healing effect of hoichunyanggyuksan and yongseksan. The J of Oriental Medical Surgery, Ophthalmology & Otolaryngology 1999;12(1):47-78.
|
4 |
Hwang TG, Shi S. Jung-yak-bang-je-hyun-dae -yeon-gu-dae-jeon. Baiging: Science Publishing; 1996, p. 1256.
|
5 |
Song IB. Sa-sang-ui-hak. Seoul: Jip-mun-dang; 1997, p. 397-8.
|
6 |
Marchi ED, Baldassari F, Bononi A, Wieckowski MR, Pinton P. Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and Protein Kniase C. Oxidative Medicine and Cellular Longevity 2013;1013:1-11.
|
7 |
Savini I., Catani MV, Evangelista D, Gasperi V, Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013;14:10497-537.
DOI
ScienceOn
|
8 |
Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 2002;366:377-91.
DOI
ScienceOn
|
9 |
Ferre P, Foretz M, Azzout-Marniche D, Becard D, Foufelle F. Sterol-regulatory-element-binding protein 1c mediates insulin action on hepatic gene expression. Biochemical Society Transactions 2001;29(4):547-52.
DOI
ScienceOn
|
10 |
Horton JD. Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochemical Society Transactions 2001; 30(6):1091-5.
DOI
|
11 |
Munday MR. Regulation of mammalian acetyl-CoA carboxylase. Biochem Soc Trans 2002;30(6) :1059-64.
|
12 |
Weber LW, Boll M, Stampfl A. Maintaining cholesterol homeostasis: sterol regulatory elementbinding proteins. World J Gastroenterol 2004; 10(21):3081-7.
|
13 |
Lan F, Cacicedo JM., Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008;283(41):27628-35.
DOI
ScienceOn
|
14 |
Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Milne JC., Elliott PJ et al. AMPK regulates energy expenditure by modulating metabolism and SIRT1 activity. Nature 2009;458(7241):1056-60.
DOI
ScienceOn
|
15 |
Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997;89:331-40.
DOI
ScienceOn
|
16 |
Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109:1125-31.
DOI
|
17 |
Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell Mol Life Sci 2005;62(16) :1784-803.
DOI
ScienceOn
|
18 |
Walker AK, Yang FJ, Jiang KR, Ji JY, Watts JL et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes & Development 2010;24 :1403-17.
DOI
ScienceOn
|
19 |
Lee TH, Jo MJ, Park SJ, Lee JR, Back YD, Kim JR et al. Inhibitory effects of hoechunyanggyeok -san on inflammation in Vivo and in Vitro. Korean J Oriental Physiology & Pathology 2009; 23(6):1341-891.
|
20 |
Gong JH. Man-byeong-hoe-chun. Seoul: Haeng-rim -seo-won; 1972, p. 16.
|
21 |
Kim JH, Jo GJ, Choi GM, Han JH, Yoon DK, Kim SM. The relationship between plasma Visfatin level, obesity and metabolic syndrome in women without diabetes. Korean J Obes 2009;18(1):15-23.
|
22 |
Speigelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104(4) :531-43.
DOI
ScienceOn
|
23 |
Kitada M, Koya D. SIRT1 in type 2 diabetes: mechanisms and therapeutic pontential. Diabetes Metab J 2013;37:315-25.
DOI
ScienceOn
|
24 |
Rodgers RJ, Tschop MH, Wilding JPH. Antiobesity drugs: past, present and future. Disease Models & Mechanisms 2012;5:621-6.
DOI
|
25 |
Hwang DY. Bang-yak-hap-pyeon. Seoul: Yeongrim- sa; 1985, p. 304-5.
|
26 |
Hong JS. Effect of Hoechounyanggeuksan on the glucose in diabetic rats induced by streptozotocin. J. of Oriental Medicine 1991;14:397-412.
|
27 |
Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya K. Sirtuins and renal disease: relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013;124:153-64.
DOI
|
28 |
Ruderman N, Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 2004;3:340-51.
DOI
ScienceOn
|
29 |
Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013;5:1218-40.
DOI
|
30 |
Li Y, Xu SQ, Mihaylova MM, Zheng B, Hou XY et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metabolism 2011;13:376-88.
DOI
ScienceOn
|